HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Azimexone and cysteine hydrazide in the treatment of allergic encephalomyelitis.

Abstract
In the course of allergic encephalomyelitis (EAE) in chickens, azimexone suppressed the production of the specific IgM immunoglobulins. Moreover, it decreased the level of haptoglobin and sialic acid but stimulated the activity of antitrypsin. It was also observed to reduce the production of the plasmatic cells in the spleen. L-cysteine hydrazide hydrochloride decreased the level of sialic acid in EAE; intensified the activity of trypsin inhibitor and exerted no effect upon the level of antimyelin antibodies.
AuthorsB Błaszczyk, J Giełdanowski, M Woźniak, W Dobryszycka, E M Lemmel, M Katkiewicz, M Viljanen
JournalArchivum immunologiae et therapiae experimentalis (Arch Immunol Ther Exp (Warsz)) Vol. 36 Issue 3 Pg. 217-27 ( 1988) ISSN: 0004-069X [Print] Switzerland
PMID3266915 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Aziridines
  • Azirines
  • alpha 1-Antitrypsin
  • azimexon
  • cysteine hydrazide
  • Cysteine
Topics
  • Animals
  • Autoantibodies (immunology)
  • Aziridines (therapeutic use)
  • Azirines (therapeutic use)
  • Chickens
  • Cysteine (analogs & derivatives, therapeutic use)
  • Encephalomyelitis, Autoimmune, Experimental (drug therapy, immunology)
  • Myelin Sheath (immunology)
  • alpha 1-Antitrypsin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: